Solmeyea

Solmeyea is a biotechnology company that operates a patented platform to transform industrial CO2 emissions into high-value, carbon-negative bioproducts. Using proprietary white microalgae strains, the company’s vertical farming technology captures emissions at the source to produce sustainable ingredients, including protein-rich powders with complete amino-acid profiles, natural antioxidants, and lipids. By co-locating its modular, industrial-scale production units next to CO2-emitting industrial plants, Solmeyea minimizes logistics costs and energy requirements while converting waste into a circular resource. This process is significantly more efficient than conventional farming, requiring substantially less land and water while providing a scalable, climate-positive alternative to traditional feedstocks.

The company’s solutions target manufacturers in the food, nutraceutical, pharmaceutical, cosmetic, and bio-material sectors seeking sustainable, high-functionality ingredients. By enabling companies to utilize captured carbon to create feed and food products, Solmeyea helps its partners address regulatory pressures, improve ESG performance, and reduce their carbon footprint. Founded in 2019 and headquartered in Greece, the venture has received validation from various European programs and organizations, including EIT Food and Climate-KIC, and currently maintains pilot production capabilities to support its mission of enhancing global food security while promoting a circular bio-economy.